Decompressive Hemicraniectomy for Severe Brain Swelling

Indications and Outcomes

• Decompressive hemicraniectomy (DH) should be performed in patients with refractory intracranial hypertension due to severe brain swelling from stroke or traumatic brain injury when medical management fails, as it significantly reduces mortality despite increased risk of disability in survivors, according to the American Heart Association 1, 2, 3
• DH with dural expansion should be considered in patients with swollen supratentorial hemispheric ischemic stroke who continue to deteriorate neurologically despite medical management, as recommended by the American Stroke Association 1, 4
• The American College of Surgeons suggests that DH is indicated for control of refractory intracranial pressure in the early phase of Traumatic Brain Injury (TBI) 2, 3
• The Brain Injury Foundation indicates that specific indications for DH in TBI include removal of symptomatic extradural hematoma regardless of location, and removal of significant acute subdural hematoma 3
• The Neurocritical Care Society recommends that DH significantly reduces mortality (by approximately 50%) compared to medical treatment alone, with a mortality rate of 26.9% in the DH group versus 48.9% in the medical group, as seen in the RESCUE-ICP study 2, 3

Technical Considerations and Decision-Making

• The American Association of Neurological Surgeons suggests that early intervention before clinical signs of brainstem compression develop yields better outcomes, and that the most commonly used technique is a large temporal craniectomy (>100 cm²) with enlarged dura mater plasty 2, 3
• The Congress of Neurological Surgeons recommends that a wide craniectomy with dural expansion is crucial for adequate ICP reduction, and that both unilateral (lateral) and bifrontal approaches are used, with the choice potentially depending on the location of pathology 5, 6
• The American Medical Association indicates that the decision to perform DH should involve multidisciplinary discussion, and that age is an important consideration, with most studies excluding patients above 60-70 years 2, 3

Post-Surgical Management and Monitoring

• The Society of Critical Care Medicine suggests that close monitoring for signs of neurological worsening is essential, and that intracranial pressure monitoring is suggested after severe TBI in patients with signs of high ICP on brain CT scan, extracranial surgical procedures, or cases where neurological evaluation is not feasible 2
• The American Academy of Neurology recommends that osmotic therapy is reasonable for patients with clinical deterioration from cerebral swelling, and that brief moderate hyperventilation may be used as a bridge to more definitive therapy 7

Decompressive Hemicraniectomy for Increased Intracranial Pressure

Primary Indications by Etiology

• The American Heart Association recommends decompressive hemicraniectomy for malignant MCA infarction in patients with impaired consciousness and >50% MCA territory edema with midline shift, with a Class I, Level A Evidence recommendation 8, 9
• Decompressive hemicraniectomy is indicated for traumatic brain injury when intracranial pressure remains elevated despite maximal medical therapy, with a significant reduction in mortality 8, 9
• The American Stroke Association suggests decompressive hemicraniectomy for cerebellar infarction when neurological signs of brainstem compression are present, with a Class III, Level C Evidence recommendation 8, 9, 10

Absolute Contraindications

• Decompressive hemicraniectomy is contraindicated in patients with bilateral, nonreactive, non-drug-induced pupillary dilation with coma, and in those with severe comorbidity, such as severe heart failure or incurable neoplasia 8, 9
• The American College of Surgeons recommends against decompressive hemicraniectomy in patients with clinical or radiological signs of severe, irreversible brainstem ischemia 8, 9

Medical Management Limitations

• Controlled hyperventilation and/or mannitol or hypertonic saline have little value once a decision against craniectomy is made, as these measures show only transitory effects and are associated with rebound phenomena after discontinuation, potentially increasing intracranial pressure 8, 9
• The American Academy of Neurology recommends against the use of corticosteroids, hypotonic fluids, and sedatives (except benzodiazepines for alcohol withdrawal) in patients with increased intracranial pressure 8, 9, 10

Outcomes and Prognosis

• Decompressive hemicraniectomy significantly reduces mortality, with a number needed to treat of approximately 2 to prevent one death, despite increased risk of disability in survivors 10
• The American Association of Neurological Surgeons reports that at 12 months post-injury, 45.4% of decompressive hemicraniectomy patients had favorable outcomes versus 32.4% with medical management alone 11

Evidence‑Based Recommendations for Decompressive Craniectomy

Indications by Pathology

Malignant Middle Cerebral Artery (MCA) Infarction

• A fronto‑parieto‑temporo‑occipital craniectomy with a bone flap ≥12 cm in diameter, combined with durotomy and expansive duroplasty, is the standard operative technique for large MCA territory edema. [12][13]

Cerebellar Infarction

• When brain‑stem compression signs appear, the craniectomy should be extended to the transverse sinus and include a foramen magnum opening to achieve adequate posterior fossa decompression. [12][13]
• Unlike supratentorial strokes, ischemic cerebellar tissue should be resected together with durotomy and duroplasty to relieve mass effect. 12
• In the presence of hydrocephalus, external ventricular drainage with intracranial pressure (ICP) monitoring must be placed; isolated shunt placement without craniectomy is contraindicated. [12][13]

Hemodynamic and Medical Management

• Maintain cerebral perfusion pressure (CPP) > 60 mm Hg using volume replacement and/or catecholamine infusion during the pre‑operative phase. 13
• Continuous CPP monitoring with a target > 60 mm Hg is recommended throughout the peri‑operative period. 13

Technical Specifications

• The craniectomy bone flap must be ≥12 cm in diameter to provide sufficient decompression and prevent persistent herniation. [12][13]
• Intra‑operative placement of an ICP monitor is advised to allow immediate postoperative pressure assessment. [12][13]

Imaging and Monitoring

• A control CT scan should be obtained at 24 hours post‑procedure (or earlier if clinical signs of rising ICP appear) to evaluate decompression adequacy and detect complications. [12][13]

Peri‑operative Pitfalls and Contraindications

• Inadequate craniectomy size (<12 cm) is associated with insufficient decompression and ongoing brain herniation. 12
• Coagulation abnormalities must be corrected before surgery; fibrinogen levels should be normalized and platelet transfusion considered when antiplatelet agents have been used. [12][13]
• Shunt placement without concurrent craniectomy for cerebellar infarction with hydrocephalus provides no benefit and is contraindicated. 12

Level of evidence: not explicitly stated in the cited sources.